Dr. Lee is a board-certified transplant hepatologist and gastroenterologist providing individualized, patient-centered care for complex liver diseases, cirrhosis, liver cancer, and post-liver transplant complications.
Brian T. Lee, MD, is a board-certified transplant hepatologist at Hoag Digestive Health Institute, providing comprehensive care for patients with complex liver disease. He practices in Newport Beach and Irvine, with clinical interests that include cirrhosis, liver cancer, autoimmune and rare liver diseases, and alloimmune complications following liver transplantation.
Dr. Lee believes in delivering evidence-based medicine while taking time to understand each patient’s story, offering individualized care tailored to each person’s needs. He earned his medical degree from Rush Medical College in Chicago, IL and completed residency and gastroenterology fellowship training at USC/LAC+USC in Los Angeles, CA, where he received multiple awards for excellence in patient-centered care. He completed advanced fellowship training in transplant hepatology at The Mount Sinai Hospital In New York, NY. He joined Hoag in 2022 and currently serves as the Director of the Hoag Liver Program.
He also serves as a principal investigator for several clinical trials in hepatology and continues to contribute to the field through active research and regular publications.
Cirrhosis
Hoag uses specialized imaging and testing to diagnose cirrhosis, a serious stage of liver disease that often develops gradually and may go unnoticed until complications arise.
Fatty Liver Disease
Hoag uses advanced diagnostic technologies to identify fatty liver disease, a common condition that can quietly worsen and lead to inflammation or scarring over time.
Fibrosis
Hoag uses noninvasive diagnostic tools to detect liver fibrosis, an early stage of scarring that can progress without clear symptoms if left untreated.
Hepatitis B
Hoag uses comprehensive diagnostic testing to identify hepatitis B, a viral liver infection that may remain asymptomatic for years while causing progressive liver damage.
Hepatocellular Cancer
Hoag uses advanced imaging and diagnostic technologies to accurately detect hepatocellular cancer, a primary liver cancer that often develops silently in patients with underlying liver disease.
Metastatic Liver Cancer
Hoag uses the latest diagnostic technologies to accurately detect metastatic liver cancer, a condition that can be difficult to identify due to subtle symptoms.
Triple board-certified in internal medicine, gastroenterology, and transplant hepatology.
USC Choi Family Excellence in Patient-Centered Care Award recipient
Super Doctors, Southern California Rising Star
Programs
Liver Program
Hoag Digestive Health Institute
From advanced diagnostics to novel treatments and groundbreaking clinical trials, patients have unique access to the most innovative and comprehensive therapies for any stage of liver disease.
More about this programGet in touch to schedule a consultation with the Digestive Health Institute.
Stay up-to-date on the latest news from Hoag
By submitting this request, you agree to receive communications from Hoag and accept our Privacy Policy and Terms of Use.